marketcaparena
Search

    KVUE

    Kenvue Inc.

    Company overview

    Market capitalization
    $34.34B
    Employees
    21,780
    Latest publication
    2026-09-29
    About Kenvue Inc.

    Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20272026-06-28 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue3,955,000,000USD3,909,000,000USD3,780,000,000USD3,764,000,000USD3,839,000,000USD3,741,000,000USD3,662,000,000USD3,899,000,000USD
    Cost Of Revenue1,654,000,000USD1,607,000,000USD1,643,000,000USD1,538,000,000USD1,578,000,000USD1,573,000,000USD1,592,000,000USD1,617,000,000USD
    Gross Profit2,301,000,000USD2,302,000,000USD2,137,000,000USD2,226,000,000USD2,261,000,000USD2,168,000,000USD2,070,000,000USD2,282,000,000USD
    Research Development94,000,000USD84,000,000USD——91,000,000USD99,000,000USD106,000,000USD97,000,000USD
    Selling General Administrative1,537,000,000USD1,453,000,000USD1,535,000,000USD1,512,000,000USD1,504,000,000USD1,537,000,000USD403,000,000USD1,590,000,000USD
    Total Operating Expenses1,602,000,000USD1,453,000,000USD1,312,000,000USD1,597,000,000USD1,569,000,000USD1,610,000,000USD1,587,000,000USD1,628,000,000USD
    Operating Income699,000,000USD855,000,000USD825,000,000USD629,000,000USD692,000,000USD558,000,000USD483,000,000USD654,000,000USD
    Total Other Income Expense Net-101,000,000USD-183,000,000USD-398,000,000USD-103,000,000USD-104,000,000USD-100,000,000USD-137,000,000USD-77,000,000USD
    Interest Expense103,000,000USD95,000,000USD98,000,000USD93,000,000USD107,000,000USD107,000,000USD148,000,000USD96,000,000USD
    Income Before Tax598,000,000USD672,000,000USD427,000,000USD526,000,000USD588,000,000USD458,000,000USD346,000,000USD577,000,000USD
    Income Tax Expense142,000,000USD198,000,000USD97,000,000USD128,000,000USD168,000,000USD136,000,000USD53,000,000USD194,000,000USD
    Net Income456,000,000USD474,000,000USD330,000,000USD398,000,000USD420,000,000USD322,000,000USD293,000,000USD383,000,000USD
    Unclassified Operating Expenses—-84,000,000USD-223,000,000USD85,000,000USD-26,000,000USD-26,000,000USD1,078,000,000USD-59,000,000USD
    Interest Income—11,000,000USD11,000,000USD14,000,000USD13,000,000USD13,000,000USD——
    Net Interest Income—-95,000,000USD-98,000,000USD-93,000,000USD-94,000,000USD-94,000,000USD-95,000,000USD-96,000,000USD
    Tax Provision—198,000,000USD97,000,000USD128,000,000USD168,000,000USD136,000,000USD53,000,000USD194,000,000USD
    Net Income From Continuing Ops—474,000,000USD330,000,000USD398,000,000USD420,000,000USD322,000,000USD293,000,000USD383,000,000USD
    Ebit—767,000,000USD525,000,000USD619,000,000USD695,000,000USD565,000,000USD494,000,000USD673,000,000USD
    Ebitda—910,000,000USD663,000,000USD760,000,000USD837,000,000USD701,000,000USD644,000,000USD855,000,000USD
    Depreciation And Amortization—143,000,000USD138,000,000USD141,000,000USD142,000,000USD136,000,000USD150,000,000USD182,000,000USD
    Reconciled Depreciation—143,000,000USD138,000,000USD141,000,000USD142,000,000USD136,000,000USD150,000,000USD182,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20192019-12-31 · USD
    Total Revenue15,124,000,000USD15,455,000,000USD15,444,000,000USD14,950,000,000USD15,054,000,000USD14,324,000,000USD
    Cost Of Revenue6,332,000,000USD6,496,000,000USD6,801,000,000USD6,665,000,000USD6,635,000,000USD6,662,000,000USD
    Gross Profit8,792,000,000USD8,959,000,000USD8,643,000,000USD8,285,000,000USD8,419,000,000USD7,662,000,000USD
    Research Development382,000,000USD—399,000,000USD375,000,000USD355,000,000USD391,000,000USD
    Selling General Administrative6,088,000,000USD4,392,000,000USD4,333,000,000USD4,277,000,000USD4,023,000,000USD3,941,000,000USD
    Unclassified Operating Expenses-382,000,000USD1,091,000,000USD—958,000,000USD1,121,000,000USD227,000,000USD
    Total Operating Expenses6,088,000,000USD7,118,000,000USD6,131,000,000USD5,610,000,000USD5,499,000,000USD5,816,000,000USD
    Operating Income2,704,000,000USD1,841,000,000USD2,512,000,000USD2,675,000,000USD2,920,000,000USD1,846,000,000USD
    Interest Income51,000,000USD53,000,000USD108,000,000USD0USD0USD—
    Interest Expense379,000,000USD431,000,000USD358,000,000USD0USD0USD—
    Net Interest Income-379,000,000USD-378,000,000USD-250,000,000USD0USD0USD—
    Income Before Tax1,999,000,000USD1,415,000,000USD2,190,000,000USD2,637,000,000USD2,925,000,000USD2,120,000,000USD
    Income Tax Expense529,000,000USD385,000,000USD526,000,000USD573,000,000USD847,000,000USD685,000,000USD
    Tax Provision529,000,000USD385,000,000USD526,000,000USD550,000,000USD894,000,000USD685,000,000USD
    Net Income1,470,000,000USD1,030,000,000USD1,664,000,000USD2,064,000,000USD2,078,000,000USD1,435,000,000USD
    Net Income From Continuing Ops1,470,000,000USD1,030,000,000USD1,664,000,000USD2,087,000,000USD2,031,000,000USD1,435,000,000USD
    Ebit2,378,000,000USD1,846,000,000USD2,548,000,000USD2,637,000,000USD2,925,000,000USD2,399,000,000USD
    Ebitda2,935,000,000USD2,468,000,000USD3,175,000,000USD3,281,000,000USD3,656,000,000USD3,108,000,000USD
    Depreciation And Amortization557,000,000USD622,000,000USD627,000,000USD644,000,000USD731,000,000USD709,000,000USD
    Reconciled Depreciation557,000,000USD622,000,000USD627,000,000USD644,000,000USD731,000,000USD709,000,000USD
    Total Other Income Expense Net-705,000,000USD-426,000,000USD-322,000,000USD-38,000,000USD5,000,000USD274,000,000USD
    Selling And Marketing Expenses—1,635,000,000USD1,349,000,000USD——1,257,000,000USD
    Net Income Applicable To Common Shares———2,087,000,000USD2,031,000,000USD1,435,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20272026-06-28 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets26,735,000,000USD26,854,000,000USD27,076,000,000USD27,248,000,000USD27,132,000,000USD26,257,000,000USD25,601,000,000USD26,925,000,000USD
    Cash And Equivalents1,110,000,000USD———————
    Total Current Assets5,899,000,000USD5,795,000,000USD5,697,000,000USD6,032,000,000USD5,854,000,000USD5,710,000,000USD5,525,000,000USD5,941,000,000USD
    Other Current Assets141,000,000USD135,000,000USD155,000,000USD152,000,000USD152,000,000USD156,000,000USD205,000,000USD210,000,000USD
    Other Non Current Assets692,000,000USD———————
    Total Liabilities16,182,000,000USD———————
    Total Current Liabilities5,867,000,000USD5,896,000,000USD5,945,000,000USD6,156,000,000USD5,988,000,000USD6,666,000,000USD5,739,000,000USD5,946,000,000USD
    Other Current Liabilities1,040,000,000USD———————
    Other Non Current Liabilities572,000,000USD———————
    Total Stockholder Equity10,553,000,000USD10,608,000,000USD10,765,000,000USD10,634,000,000USD10,730,000,000USD10,053,000,000USD9,668,000,000USD10,644,000,000USD
    Total Equity Including Noncontrolling Interest10,553,000,000USD———————
    Short Long Term Debt1,405,000,000USD1,589,000,000USD1,453,000,000USD1,913,000,000USD1,553,000,000USD2,431,000,000USD1,552,000,000USD1,648,000,000USD
    Net Receivables2,476,000,000USD2,911,000,000USD2,814,000,000USD2,947,000,000USD2,856,000,000USD2,817,000,000USD2,659,000,000USD2,854,000,000USD
    Inventory1,722,000,000USD1,674,000,000USD1,666,000,000USD1,794,000,000USD1,776,000,000USD1,680,000,000USD1,591,000,000USD1,820,000,000USD
    Property Plant Equipment Net2,226,000,000USD2,208,000,000USD2,212,000,000USD2,092,000,000USD2,038,000,000USD1,927,000,000USD1,849,000,000USD1,776,000,000USD
    Goodwill9,265,000,000USD———————
    Intangible Assets8,406,000,000USD8,540,000,000USD8,694,000,000USD8,716,000,000USD8,804,000,000USD8,586,000,000USD8,474,000,000USD8,887,000,000USD
    Accounts Payable2,577,000,000USD2,533,000,000USD2,473,000,000USD2,445,000,000USD2,568,000,000USD2,332,000,000USD2,254,000,000USD2,274,000,000USD
    Short Term Debt1,406,000,000USD1,589,000,000USD1,453,000,000USD1,951,000,000USD1,591,000,000USD2,468,000,000USD1,588,000,000USD1,688,000,000USD
    Common Stock19,000,000USD19,000,000USD19,000,000USD19,000,000USD19,000,000USD19,000,000USD19,000,000USD19,000,000USD
    Retained Earnings-70,000,000USD-128,000,000USD-204,000,000USD-136,000,000USD-136,000,000USD-163,000,000USD-93,000,000USD7,000,000USD
    Accumulated Other Comprehensive Income-5,354,000,000USD-5,206,000,000USD-4,959,000,000USD-5,130,000,000USD-5,072,000,000USD-5,699,000,000USD-6,146,000,000USD-5,359,000,000USD
    Total Liab—16,246,000,000USD16,311,000,000USD16,614,000,000USD16,402,000,000USD16,204,000,000USD15,933,000,000USD16,281,000,000USD
    Other Current Liab—1,678,000,000USD1,914,000,000USD1,760,000,000USD1,687,000,000USD1,630,000,000USD1,741,000,000USD1,735,000,000USD
    Capital Stock—19,000,000USD19,000,000USD19,000,000USD19,000,000USD19,000,000USD19,000,000USD19,000,000USD
    Good Will—9,376,000,000USD9,509,000,000USD9,441,000,000USD9,486,000,000USD9,136,000,000USD8,843,000,000USD9,297,000,000USD
    Cash—1,075,000,000USD1,062,000,000USD1,139,000,000USD1,070,000,000USD1,057,000,000USD1,070,000,000USD1,057,000,000USD
    Cash And Short Term Investments—1,075,000,000USD1,062,000,000USD1,139,000,000USD1,070,000,000USD1,057,000,000USD1,070,000,000USD1,057,000,000USD
    Net Debt—7,586,000,000USD7,462,000,000USD7,970,000,000USD7,674,000,000USD7,796,000,000USD7,649,000,000USD7,770,000,000USD
    Short Long Term Debt Total—8,661,000,000USD8,524,000,000USD9,109,000,000USD8,744,000,000USD8,853,000,000USD8,719,000,000USD8,827,000,000USD
    Long Term Debt—7,072,000,000USD6,938,000,000USD7,060,000,000USD7,057,000,000USD6,196,750,000USD6,942,000,000USD7,053,000,000USD
    Common Stock Shares Outstanding—1,922,000,000shares1,920,000,000shares1,923,000,000shares1,927,000,000shares1,925,000,000shares1,929,000,000shares1,924,000,000shares
    Non Current Assets Total—21,059,000,000USD21,379,000,000USD21,216,000,000USD21,278,000,000USD20,547,000,000USD20,076,000,000USD20,984,000,000USD
    Non Current Liabilities Total—10,350,000,000USD10,366,000,000USD10,458,000,000USD10,414,000,000USD9,538,000,000USD10,194,000,000USD10,335,000,000USD
    Non Currrent Assets Other—703,000,000USD727,000,000USD729,000,000USD730,000,000USD699,000,000USD726,000,000USD796,000,000USD
    Net Working Capital—-101,000,000USD-248,000,000USD-124,000,000USD-134,000,000USD-956,000,000USD-214,000,000USD-5,000,000USD
    Unclassified Non Current Assets—232,000,000USD237,000,000USD238,000,000USD220,000,000USD——228,000,000USD
    Unclassified Current Liabilities—-1,493,000,000USD-1,348,000,000USD-1,913,000,000USD-1,411,000,000USD-2,195,000,000USD-1,396,000,000USD-1,399,000,000USD
    Unclassified Non Current Liabilities—3,278,000,000USD3,428,000,000USD3,398,000,000USD3,357,000,000USD3,341,250,000USD3,252,000,000USD3,282,000,000USD
    Unclassified Equity—15,904,000,000USD15,890,000,000USD15,862,000,000USD15,900,000,000USD15,877,000,000USD15,869,000,000USD15,958,000,000USD
    Property Plant Equipment Gross——5,231,000,000USD———4,550,000,000USD—
    Non Current Liabilities Other——————-1,000,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Assets27,076,000,000USD25,601,000,000USD27,851,000,000USD27,316,000,000USD27,929,000,000USD29,177,000,000USD—
    Intangible Assets8,694,000,000USD8,474,000,000USD9,619,000,000USD9,853,000,000USD10,701,000,000USD11,610,000,000USD—
    Other Current Assets155,000,000USD205,000,000USD265,000,000USD123,000,000USD154,000,000USD162,000,000USD—
    Total Liab16,311,000,000USD15,933,000,000USD16,640,000,000USD7,346,000,000USD7,530,000,000USD10,821,000,000USD—
    Total Stockholder Equity10,765,000,000USD9,668,000,000USD11,211,000,000USD19,970,000,000USD20,399,000,000USD18,356,000,000USD—
    Other Current Liab1,914,000,000USD1,741,000,000USD2,094,000,000USD1,733,000,000USD1,811,000,000USD5,522,000,000USD—
    Common Stock19,000,000USD19,000,000USD19,000,000USD25,425,000,000USD24,872,000,000USD21,928,000,000USD—
    Capital Stock19,000,000USD19,000,000USD19,000,000USD19,000,000USD———
    Retained Earnings-204,000,000USD-93,000,000USD429,000,000USD0USD———
    Good Will9,509,000,000USD8,843,000,000USD9,271,000,000USD9,185,000,000USD9,810,000,000USD10,326,000,000USD—
    Cash1,062,000,000USD1,070,000,000USD1,382,000,000USD1,231,000,000USD740,000,000USD618,000,000USD—
    Cash And Short Term Investments1,062,000,000USD1,070,000,000USD1,382,000,000USD1,231,000,000USD740,000,000USD618,000,000USD—
    Total Current Assets5,697,000,000USD5,525,000,000USD6,138,000,000USD5,877,000,000USD4,927,000,000USD4,595,000,000USD—
    Total Current Liabilities5,945,000,000USD5,739,000,000USD5,481,000,000USD3,926,000,000USD4,042,000,000USD7,494,000,000USD—
    Net Debt7,462,000,000USD7,649,000,000USD7,045,000,000USD7,815,000,000USD-611,000,000USD-618,000,000USD—
    Short Term Debt1,453,000,000USD1,588,000,000USD643,000,000USD35,000,000USD47,000,000USD160,000,000USD—
    Short Long Term Debt1,453,000,000USD1,552,000,000USD599,000,000USD————
    Short Long Term Debt Total8,524,000,000USD8,719,000,000USD8,427,000,000USD9,046,000,000USD129,000,000USD320,000,000USD—
    Long Term Debt6,938,000,000USD6,942,000,000USD7,687,000,000USD8,930,000,000USD———
    Net Receivables2,814,000,000USD2,659,000,000USD2,640,000,000USD2,297,000,000USD2,331,000,000USD2,130,000,000USD—
    Inventory1,666,000,000USD1,591,000,000USD1,851,000,000USD2,226,000,000USD1,702,000,000USD1,685,000,000USD—
    Accounts Payable2,473,000,000USD2,254,000,000USD2,489,000,000USD1,829,000,000USD1,827,000,000USD1,579,000,000USD—
    Property Plant Equipment Net2,212,000,000USD1,849,000,000USD2,042,000,000USD1,820,000,000USD1,827,000,000USD1,957,000,000USD—
    Property Plant Equipment Gross5,231,000,000USD4,550,000,000USD6,243,000,000USD5,700,000,000USD5,770,000,000USD5,969,000,000USD—
    Accumulated Other Comprehensive Income-4,959,000,000USD-6,146,000,000USD-5,377,000,000USD-5,455,000,000USD-4,473,000,000USD-3,572,000,000USD—
    Common Stock Shares Outstanding1,924,000,000shares1,923,000,000shares1,915,057,047shares1,914,894,000shares1,888,973,000shares1,888,972,560shares1,888,973,000shares
    Non Current Assets Total21,379,000,000USD20,076,000,000USD21,713,000,000USD21,439,000,000USD23,002,000,000USD24,582,000,000USD—
    Non Current Liabilities Total10,366,000,000USD10,194,000,000USD11,159,000,000USD3,420,000,000USD3,488,000,000USD3,327,000,000USD—
    Non Currrent Assets Other727,000,000USD726,000,000USD623,000,000USD434,000,000USD475,000,000USD496,000,000USD—
    Net Working Capital-248,000,000USD-214,000,000USD657,000,000USD1,951,000,000USD885,000,000USD-2,899,000,000USD—
    Unclassified Non Current Assets237,000,000USD——-368,000,000USD-401,000,000USD-496,000,000USD—
    Unclassified Current Liabilities-1,348,000,000USD-1,396,000,000USD-1,238,000,000USD329,000,000USD357,000,000USD233,000,000USD—
    Unclassified Non Current Liabilities3,428,000,000USD3,252,000,000USD3,472,000,000USD-9,444,000,000USD82,000,000USD160,000,000USD—
    Unclassified Equity15,890,000,000USD15,869,000,000USD16,121,000,000USD————
    Non Current Liabilities Other—-1,000,000USD—646,000,000USD———
    Current Deferred Revenue——894,000,000USD—-129,000,000USD-160,000,000USD—
    Other Liab———3,288,000,000USD3,406,000,000USD3,167,000,000USD—
    Other Assets———515,000,000USD590,000,000USD689,000,000USD—
    Net Tangible Assets———983,000,000USD-112,000,000USD-4,867,000,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20272026-06-28 · USD
    Depreciation288,000,000USD
    Stock Based Compensation61,000,000USD
    Deferred Income Tax18,000,000USD
    Other Non Cash Items-33,000,000USD
    Change To Account Receivables-108,000,000USD
    Change To Inventory-69,000,000USD
    Change To Liabilities119,000,000USD
    Change In Working Capital-138,000,000USD
    Operating Cash Flow1,177,000,000USD
    Capital Expenditures-203,000,000USD
    Other Investing Activities42,000,000USD
    Unclassified Investing Cash Flow-84,000,000USD
    Investing Cash Flow-245,000,000USD
    Net Debt Issuance1,430,000,000USD
    Net Common Stock Issuance0USD
    Common Dividends Paid-796,000,000USD
    Other Financing Activities-16,000,000USD
    Unclassified Financing Cash Flow-1,500,000,000USD
    Financing Cash Flow-882,000,000USD
    Effect Of Forex Changes On Cash-2,000,000USD
    Change In Cash48,000,000USD
    End Cash Flow1,110,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income474,000,000USD330,000,000USD398,000,000USD420,000,000USD322,000,000USD293,000,000USD383,000,000USD58,000,000USD
    Depreciation143,000,000USD138,000,000USD141,000,000USD142,000,000USD136,000,000USD148,000,000USD182,000,000USD141,000,000USD
    Stock Based Compensation29,000,000USD30,000,000USD25,000,000USD37,000,000USD44,000,000USD54,000,000USD58,000,000USD61,000,000USD
    Other Non Cash Items18,000,000USD36,000,000USD-344,000,000USD17,000,000USD16,000,000USD76,000,000USD17,000,000USD524,000,000USD
    Change To Account Receivables-136,000,000USD35,000,000USD-96,000,000USD48,000,000USD-99,000,000USD125,000,000USD-110,000,000USD-109,000,000USD
    Change To Inventory-19,000,000USD132,000,000USD-27,000,000USD-51,000,000USD-66,000,000USD169,000,000USD62,000,000USD14,000,000USD
    Change In Working Capital-203,000,000USD417,000,000USD58,000,000USD19,000,000USD-77,000,000USD262,000,000USD-351,000,000USD-143,000,000USD
    Total Cash From Operating Activities489,000,000USD854,000,000USD294,000,000USD621,000,000USD428,000,000USD793,000,000USD249,000,000USD440,000,000USD
    Capital Expenditures-139,000,000USD-110,000,000USD-98,000,000USD-88,000,000USD-179,000,000USD-132,000,000USD-59,000,000USD-90,000,000USD
    Free Cash Flow350,000,000USD744,000,000USD196,000,000USD533,000,000USD249,000,000USD661,000,000USD190,000,000USD350,000,000USD
    Total Cashflows From Investing Activities-167,000,000USD-75,000,000USD-104,000,000USD-90,000,000USD-167,000,000USD-132,000,000USD-56,000,000USD-85,000,000USD
    Net Borrowings120,000,000USD-470,000,000USD349,000,000USD-147,000,000USD118,000,000USD-108,000,000USD208,000,000USD—
    Total Cash From Financing Activities-295,000,000USD-869,000,000USD-110,000,000USD-548,000,000USD-310,000,000USD-587,000,000USD-162,000,000USD-490,000,000USD
    Dividends Paid-398,000,000USD-1,183,000,000USD-398,000,000USD-393,000,000USD-392,000,000USD-393,000,000USD-393,000,000USD-383,000,000USD
    Sale Purchase Of Stock0USD0USD-70,000,000USD-64,000,000USD-63,000,000USD-121,000,000USD-23,000,000USD0USD
    Change In Cash13,000,000USD-77,000,000USD1,137,900,000USD-1,055,900,000USD-13,000,000USD13,000,000USD43,000,000USD-141,000,000USD
    Begin Period Cash Flow1,062,000,000USD1,139,000,000USD1,100,000USD1,057,000,000USD1,070,000,000USD1,057,000,000USD1,014,000,000USD1,155,000,000USD
    End Period Cash Flow1,075,000,000USD1,062,000,000USD1,139,000,000USD1,100,000USD1,057,000,000USD1,070,000,000USD1,057,000,000USD1,014,000,000USD
    Other Cashflows From Investing Activities-28,000,000USD-439,500,000USD-6,000,000USD-2,000,000USD12,000,000USD6,000,000USD3,000,000USD5,000,000USD
    Other Cashflows From Financing Activities-17,000,000USD-2,081,000,000USD9,000,000USD56,000,000USD27,000,000USD35,000,000USD45,000,000USD-5,000,000USD
    Unclassified Operating Cash Flow28,000,000USD-97,000,000USD16,000,000USD-14,000,000USD-13,000,000USD-40,000,000USD-40,000,000USD-201,000,000USD
    Unclassified Investing Cash Flow—474,500,000USD104,000,000USD90,000,000USD167,000,000USD126,000,000USD56,000,000USD85,000,000USD
    Unclassified Financing Cash Flow—2,865,000,000USD—————-102,000,000USD
    Investments——-104,000,000USD-90,000,000USD-167,000,000USD-132,000,000USD-56,000,000USD-85,000,000USD
    Issuance Of Capital Stock—————0USD0USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Net Income1,470,000,000USD1,030,000,000USD1,664,000,000USD-879,000,000USD1,435,000,000USD
    Depreciation557,000,000USD622,000,000USD627,000,000USD746,000,000USD709,000,000USD
    Stock Based Compensation136,000,000USD254,000,000USD188,000,000USD115,000,000USD102,000,000USD
    Other Non Cash Items90,000,000USD719,000,000USD6,000,000USD-26,000,000USD-149,000,000USD
    Change To Account Receivables-112,000,000USD-218,000,000USD44,000,000USD265,000,000USD40,000,000USD
    Change To Inventory-12,000,000USD182,000,000USD349,000,000USD109,000,000USD180,000,000USD
    Change In Working Capital52,000,000USD-571,000,000USD797,000,000USD4,242,000,000USD804,000,000USD
    Total Cash From Operating Activities2,197,000,000USD1,769,000,000USD3,168,000,000USD3,397,000,000USD2,998,000,000USD
    Capital Expenditures-475,000,000USD-434,000,000USD-469,000,000USD-229,000,000USD-289,000,000USD
    Free Cash Flow1,722,000,000USD1,335,000,000USD2,699,000,000USD3,168,000,000USD2,709,000,000USD
    Total Cashflows From Investing Activities-436,000,000USD-425,000,000USD-488,000,000USD-83,000,000USD-2,155,000,000USD
    Net Borrowings-150,000,000USD159,000,000USD8,246,000,000USD-11,000,000USD-40,000,000USD
    Total Cash From Financing Activities-1,837,000,000USD-1,565,000,000USD-2,527,000,000USD-3,457,000,000USD-685,000,000USD
    Dividends Paid-1,581,000,000USD-1,552,000,000USD-14,554,000,000USD——
    Sale Purchase Of Stock-197,000,000USD-235,000,000USD16,492,000,000USD——
    Issuance Of Capital Stock0USD0USD4,241,000,000USD——
    Change In Cash-8,000,000USD-312,000,000USD151,000,000USD-134,000,000USD147,000,000USD
    Begin Period Cash Flow1,070,000,000USD1,382,000,000USD1,231,000,000USD752,000,000USD605,000,000USD
    End Period Cash Flow1,062,000,000USD1,070,000,000USD1,382,000,000USD618,000,000USD752,000,000USD
    Other Cashflows From Investing Activities-435,500,000USD9,000,000USD-40,000,000USD146,000,000USD63,000,000USD
    Other Cashflows From Financing Activities91,000,000USD63,000,000USD-460,000,000USD-3,446,000,000USD-645,000,000USD
    Unclassified Operating Cash Flow-108,000,000USD-285,000,000USD-114,000,000USD-801,000,000USD97,000,000USD
    Unclassified Investing Cash Flow474,500,000USD425,000,000USD509,000,000USD83,000,000USD226,000,000USD
    Investments—-425,000,000USD-488,000,000USD-83,000,000USD-2,155,000,000USD
    Unclassified Financing Cash Flow——-12,251,000,000USD——
    Change To Liabilities———154,000,000USD3,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2027Quarterly · 2026-06-28SegmentEssential Health1,253,000,000USDDisclosure
    Q2 2027Quarterly · 2026-06-28SegmentSelf Care1,589,000,000USDDisclosure
    Q2 2027Quarterly · 2026-06-28SegmentSkin Health And Beauty1,113,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentEssential Health1,151,000,000USD0001944048-26-000098
    Q1 2026Quarterly · 2026-03-31SegmentSelf Care1,699,000,000USD0001944048-26-000098
    Q1 2026Quarterly · 2026-03-31SegmentSkin Health And Beauty1,059,000,000USD0001944048-26-000098
    Q4 2025Quarterly · 2025-12-31SegmentEssential Health1,148,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentSelf Care1,592,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentSkin Health And Beauty1,040,000,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyAsia Pacific2,775,000,000USD0001944048-26-000030
    FY 2025Yearly · 2025-12-31GeographyEMEA3,721,000,000USD0001944048-26-000030
    FY 2025Yearly · 2025-12-31GeographyLatin America1,369,000,000USD0001944048-26-000030
    FY 2025Yearly · 2025-12-31GeographyNorth America7,259,000,000USD0001944048-26-000030
    FY 2025Yearly · 2025-12-31SegmentEssential Health4,632,000,000USD0001944048-26-000030
    FY 2025Yearly · 2025-12-31SegmentSelf Care6,378,000,000USD0001944048-26-000030
    FY 2025Yearly · 2025-12-31SegmentSkin Health And Beauty4,114,000,000USD0001944048-26-000030
    Q3 2025Quarterly · 2025-09-30SegmentEssential Health1,162,000,000USD0001944048-25-000198
    Q3 2025Quarterly · 2025-09-30SegmentSelf Care1,564,000,000USD0001944048-25-000198
    Q3 2025Quarterly · 2025-09-30SegmentSkin Health And Beauty1,038,000,000USD0001944048-25-000198
    Q2 2025Quarterly · 2025-06-30SegmentEssential Health1,225,000,000USD0001944048-25-000177
    Q2 2025Quarterly · 2025-06-30SegmentSelf Care1,555,000,000USD0001944048-25-000177
    Q2 2025Quarterly · 2025-06-30SegmentSkin Health And Beauty1,059,000,000USD0001944048-25-000177
    Q1 2025Quarterly · 2025-03-31SegmentEssential Health1,097,000,000USD0001944048-26-000098
    Q1 2025Quarterly · 2025-03-31SegmentSelf Care1,667,000,000USD0001944048-26-000098
    Q1 2025Quarterly · 2025-03-31SegmentSkin Health And Beauty977,000,000USD0001944048-26-000098
    Q4 2024Quarterly · 2024-12-31SegmentEssential Health1,082,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentSelf Care1,569,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentSkin Health And Beauty1,011,000,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyAsia Pacific2,974,000,000USD0001944048-26-000030
    FY 2024Yearly · 2024-12-31GeographyEMEA3,559,000,000USD0001944048-26-000030
    FY 2024Yearly · 2024-12-31GeographyLatin America1,343,000,000USD0001944048-26-000030
    FY 2024Yearly · 2024-12-31GeographyNorth America7,579,000,000USD0001944048-26-000030
    FY 2024Yearly · 2024-12-31SegmentEssential Health4,688,000,000USD0001944048-26-000030
    FY 2024Yearly · 2024-12-31SegmentSelf Care6,527,000,000USD0001944048-26-000030
    FY 2024Yearly · 2024-12-31SegmentSkin Health And Beauty4,240,000,000USD0001944048-26-000030
    Q3 2024Quarterly · 2024-09-30SegmentEssential Health1,202,000,000USD0001944048-25-000198
    Q3 2024Quarterly · 2024-09-30SegmentSelf Care1,625,000,000USD0001944048-25-000198
    Q3 2024Quarterly · 2024-09-30SegmentSkin Health And Beauty1,072,000,000USD0001944048-25-000198
    FY 2023Yearly · 2023-12-31GeographyAsia Pacific3,107,000,000USD0001944048-26-000030
    FY 2023Yearly · 2023-12-31GeographyEMEA3,388,000,000USD0001944048-26-000030
    FY 2023Yearly · 2023-12-31GeographyLatin America1,339,000,000USD0001944048-26-000030
    FY 2023Yearly · 2023-12-31GeographyNorth America7,610,000,000USD0001944048-26-000030
    FY 2023Yearly · 2023-12-31SegmentEssential Health4,615,000,000USD0001944048-26-000030
    FY 2023Yearly · 2023-12-31SegmentSelf Care6,451,000,000USD0001944048-26-000030
    FY 2023Yearly · 2023-12-31SegmentSkin Health And Beauty4,378,000,000USD0001944048-26-000030
    FY 2022Yearly · 2022-12-31GeographyAsia Pacific3,146,000,000USD0001944048-25-000033
    FY 2022Yearly · 2022-12-31GeographyEMEA3,188,000,000USD0001944048-25-000033
    FY 2022Yearly · 2022-12-31GeographyLatin America1,198,000,000USD0001944048-25-000033
    FY 2022Yearly · 2022-12-31GeographyNorth America7,418,000,000USD0001944048-25-000033
    FY 2022Yearly · 2022-12-31SegmentEssential Health4,570,000,000USD0001944048-25-000033
    FY 2022Yearly · 2022-12-31SegmentSelf Care6,030,000,000USD0001944048-25-000033
    FY 2022Yearly · 2022-12-31SegmentSkin Health And Beauty4,350,000,000USD0001944048-25-000033
    FY 2021Yearly · 2021-12-31GeographyAsia Pacific3,276,000,000USD0001944048-24-000057
    FY 2021Yearly · 2021-12-31GeographyEMEA3,436,000,000USD0001944048-24-000057
    FY 2021Yearly · 2021-12-31GeographyLatin America1,058,000,000USD0001944048-24-000057
    FY 2021Yearly · 2021-12-31GeographyNorth America7,284,000,000USD0001944048-24-000057
    FY 2021Yearly · 2021-12-31SegmentEssential Health4,870,000,000USD0001944048-24-000057
    FY 2021Yearly · 2021-12-31SegmentSelf Care5,643,000,000USD0001944048-24-000057
    FY 2021Yearly · 2021-12-31SegmentSkin Health And Beauty4,541,000,000USD0001944048-24-000057

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.